| Literature DB >> 35732700 |
Tongyan Ren1, Chengmin Feng2, Jun Dong1, Hong Zhu3, Bing Wang4,5.
Abstract
Implant-associated infections limit the clinical application of implants therapy; hence, exploiting strategies to prevent biomaterial-associated infections has become important. Therefore, in this study, a series of poly (p-dioxanone) (PPDO)-coated Ag loading TiO2 nanoparticles (Ag@TiO2-PPDO) was synthesized to be applied as bacteriostatic coating materials that could be easily dispersed in organic solvent and coated onto implantable devices via temperate methods such as electrospraying. The lattice parameters of TiO2 were a = 0.504 nm, b = c = 1.05 nm, alpha = beta = gamma = 90 degree and the size of crystallite was about 13 nm, indicating that part of Ag has been embedded into crystal defects of TiO2. Both XRD and TEM determinations indicated the successful grating of PPDO on the surface of Ag@TiO2. Among Ag@TiO2 nanoparticles with various Ag loading quantities, 12% Ag@TiO2 nanoparticles exhibited relatively higher grafting efficiency and Ag contents on the surface of grafted composites. In addition, 12% Ag@TiO2-PPDO exhibited the best bacteriostatic effect in vitro owing to its higher grafted efficiency and relatively short length of PPDO segments. Subsequently, Ag@TiO2-PPDO was coated on the surface of a poly lactic-co-glycolic acid (PLGA) electrospun membrane via the electrospraying method. Finally, the in vivo bacteriostatic effect of 12% Ag@TiO2-PPDO coating was verified by implanting 12% Ag@TiO2-PPDO-coated PLGA membrane into a rat subcutaneously combined with an injection of Staphylococcus aureus at implanting sites.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35732700 PMCID: PMC9217793 DOI: 10.1038/s41598-022-14814-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Synthetic processes of Ag@TiO2-PPDO and Ag@TiO2 NP-coated PLGA/PLCA electrospinning membrane.
Series of Ag@TiO2-PPDOs.
| Series | Feed weight ratio of Ag to TiO2 nanoparticles | Feed weight ratio of Ag @TiO2 to PDO |
|---|---|---|
| 8% Ag@ TiO2 PPDO | 8:100 | 1:20 |
| 12% Ag@ TiO2 PPDO | 12:100 | 1:20 |
| 16% Ag@ TiO2 PPDO | 16:100 | 1:20 |
| 20% Ag@ TiO2 PPDO | 20:100 | 1:20 |
Figure 2(a) XRD spectra of Ag@TiO2-PPDOs (red arrows indicates peaks of PPDO crystal, the green dotted line indicates peaks of TiO2 crystal, the red dotted line indicates peaks of Ag); (b) TEM of Ag@TiO2-PPDOs; (c) TG curves of Ag@TiO2-PPDOs; (d) Raman spectrum of Ag@TiO2-PPDOs; (e) Affection of Ag content in Ag@TiO2 on the disperse stability of Ag@TiO2-PPDO in organic solvent; (f) UV-DRS determination of Ag@TiO2-PPDOs.
Figure 3(a) Ag content detected by ICP; (b) SEM–EDS mapping of Ag@TiO2-PPDOs.
Figure 4(a) Bacteriostatic zone diameter of Ag@TiO2-PPDOs with different dosage; (b) Correlations of bacteriostatic zone diameter with Ag loading contents and dosage.
Figure 5SEM photographs of implanted PLGA electrospun membrane and Ag@TiO2-PPDO-coated PLGA membrane. (Red square indicates PLGA membranes under Ag@TiO2-PPDO coating).
Figure 6(a) H&E staining (green arrows indicate the implanted membranes); (b) TNF-α immumohistochemical staining of subcutaneous tissues treated with different materials; (c) Statistical IOD of TNF-α immumohistochemical staining.